Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center Identifier:
First received: June 6, 2002
Last updated: October 26, 2011
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)